CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » Gastrointestinal Cancers » Liver Cancer

RESEARCH REPORT 

High Vitamin E Intake May Lower Liver Cancer Risk

By Anna Azvolinsky, PhD1 | July 17, 2012
1Freelance Science Writer and CancerNetwork Contributor. Follow Her on Twitter

A new study finds higher levels of vitamin E(Drug information on vitamin e) consumption could stave off liver cancer. The study, aiming to assess link between dietary habits and liver cancer incidence, followed 132,837 men and women for an average of at least 5 years and is published in the Journal of the National Cancer Institute. All of the participants were from China.

Vitamin E

Vitamin E intake from food and from supplements was inversely associated with liver cancer risk (P = .01). The association held up for those who had a family history of liver disease and those who self-reported liver disease. Among the participants, 267 cases of liver cancer were reported—118 women and 149 men. The data was not statistically significant when only the male cohort data was analyzed. However, as there is no current evidence for sex-based difference of vitamin E metabolism, the authors attribute the result to “random fluctuation” and the relatively few liver cancer cases reported in the study.

“Our finding is consistent with the biological properties of vitamin E and experimental results,” said Xiao-Ou Shu, MD, PhD, of the Vanderbilt Epidemiology Center in Nashville, Tennessee and one of the lead authors of the study.
 
“The vitamin E and liver cancer association was seen for subjects with and without liver diseases in our study, suggesting that the effect of vitamin E do not restrict to a particular type of liver cancer, such as the one caused by the hepatitis B virus,” said Shu. “Thus, the finding of our study should be able to be generalized to other populations.”

Shu cautioned that a more definitive answer can only be obtained when the American Chinese and the general US population are further studied.

The study also found that vitamin C supplements (but not dietary vitamin C) and multivitamin supplements were associated with an increased risk of liver cancer among those participants who either had self-reported liver disease or had a family history of liver cancer. It should be noted that the statistical power for this analysis was low due to the smaller sample size. Additionally, those participants with liver disease or a family history of liver cancer were more likely to take vitamin supplements, therefore a reverse causation is possible, highlight the authors.

The study found no association of vitamin B or calcium intake and risk of liver cancer.

The participants who developed liver cancer tended to be older, to have a lower education, a family history of liver cancer, and a history of viral hepatitis compared to those who remained without cancer during the study follow-up. Women with liver cancer were more likely to have a higher body mass index while men were more likely to have a history of diabetes, a higher fat intake, and a lower family income. Neither smoking nor drinking habits differed among those who developed liver cancer and those who did not have liver cancer during the study.

Liver Cancer

Liver cancer is the third most common cause of cancer mortality worldwide. More than half of all liver cancers occur in China. It is the fifth most common cancer in men and the seventh most common in women according to the International Agency for Research on Cancer. Among the known risk factors are hepatitis B and hepatitis C infections as well as chronic alcohol(Drug information on alcohol) consumption and aflatoxin. A prevalent hypothesis of liver carcinogenesis is the chronic DNA damage from perpetual inflammation, which can promote cancer cell growth.

“The contribution of genetic factors to liver cancer has not been well investigated and is likely to play an important role,” said Shu. “In my opinion, environmental factors are the main driving force behind the high incidence of liver cancer among Asians,” Shu added.

Study Design and Results

Vitamin E intake from both diet and supplements was assessed among those enrolled in the Shanghai Women’s Health Study and the Shanghai Men’s Health Study. The participants filled out food questionnaires that were followed up by in-person interviews.

The two cohorts were studied by both Vanderbilt University and the Shanghai Cancer Institute. The participants were enrolled for 3 years starting in 1997 and followed until 2006. The men’s cohort was followed up for an average of 5.5 years and the women’s cohort for an average of 10.9 years. All participants were between 40 and 74 years of age at recruitment.

Vitamin E and A, zinc, copper, and selenium(Drug information on selenium) in the diet are thought to reduce liver cancer rates by reducing hepatitis infections. Vitamin E has been previously shown to improve liver function in patients with a viral hepatitis infection, according to the authors. However, compared to the current study, the only studies assessing liver cancer and dietary intake were small, retrospective cohort studies.

A recent study showed vitamin E supplements do not prevent prostate cancer and may actually increase its incidence. “The etiology for cancers differs greatly from cancer to cancer, and sometimes across subtypes of a same cancer. Therefore, it is not uncommon that a factor protects one type of cancer but not another type of cancer,” said Shu. Additionally, the current study participants got vitamin E mainly from the diet without ingesting higher levels of vitamin E from supplements. The effect of vitamin E can differ depending on which of the eight types is ingested and which population is studied.

In their discussion, the authors point out that because fewer than 17.5% of study participants took vitamin supplements and because food in China is not fortified with vitamins and minerals, the Chinese population is a unique way to study dietary influences on disease outcomes. The authors plan to further investigate the role of vitamin E intake on liver cancer risk by measuring the blood levels of vitamin E and markers of hepatitis B infection. “We would also like to explore the role of genetic factors in this association,” said Shu.

What are excellent sources of dietary vitamin E? Rich vitamin E foods include spinach, Swiss chard, peppers, and other dark green vegetables, almonds, sunflower seeds and other nuts, tropical fruits, and vegetable oil. “Personally, I would prefer to get my vitamin E from diet instead of supplements, as many vitamin E rich foods also contains other nutrients and phytochemicals that are beneficial to health,” said Shu.

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.






 
RELATED CONTENT

Aspirin Reduces Risk of Liver Cancer and Death From Chronic Liver Disease
November 29, 2012
Targeted Therapy: Its Status and Promise in Selected Solid Tumors Part I
ONCOLOGY,  October 23, 2012
High Vitamin E Intake May Lower Liver Cancer Risk
July 17, 2012
A 58-Year-Old Man Presents With Abdominal Pain and Jaundice
April 30, 2012
Tremelimumab Shows Efficacy in Hepatocellular Carcinoma and Chronic Hepatitis C
April 3, 2012
 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
   SEARCH MEDICA RX
   Browse drugs by name:
A B C D E F G H I J
K L M N O P Q R S T
U V W X Y Z All      
   Search for drugs:
Search

 

 
FROM PHYSICIANS PRACTICE
Primary Care Can't Thrive Without Nurse Practitioners
Courtney H. Lyder, ND,  May 17, 2013
With a projected shortfall of primary-care physicians, it's time for alternate solutions to patient care. Nurse practitioners are one logical remedy.
VWhat Physicians Can Learn from the Allscripts EHR Lawsuit
Marisa Torrieri,  May 16, 2013
Lawsuit prompts question: What should physicians do to ensure they end up with a great EHR instead of buyer’s remorse?
Eight Ways ICD-9 Will Still Matter to Medical Practices
Brenda Edwards, CPC,  May 15, 2013
What should your medical practice do with your ICD-9-CM book after October 1, 2014? Keep it.
Seven Ways Technology Can Speed Up Patient Collections
Cheyenne Brinson,  May 15, 2013
Failing to adopt widely available billing and collections technology can cost medical practices big. Here's how to do it right.
Four Reasons Private Medical Practice is Becoming Extinct
Carol Stryker,  May 15, 2013
It’s becoming increasingly difficult for private medical practices to thrive. Here’s what’s driving the trend toward consolidation.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Colorectal Lesions
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • “This Is My Last Day on Earth”
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • The ABCDEs of Moles and Melanomas
  • “This Is My Last Day on Earth”
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Colorectal Lesions
  • ONS: Understanding Spirituality and How It Can Be Used to Help Patients
  • Bone Metastases
  • Palliative Radiotherapy in Elderly Patients With Bone Metastases Improves Quality of Life
  • Staying Fit Could Ward Off Lung and Colorectal Cancer for Middle-Age Men
  • Obesity Impairs Efficacy of L-Asparaginase in Leukemia Treatment
  • New AUA Guidelines for Prostate Cancer Screening
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • “This Is My Last Day on Earth”
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Patient Quality of Life Endpoints in Oncology Trials, Part II
  • Who's Coding Whom?
  • “How Do I Say This Nicely? Your Oncologist Wasn't Following Guidelines”
  • Preventing Exposure to Hazardous Drugs
  • Cancer Metabolism as a Therapeutic Target
  • Study: Cholesterol Drugs Reduced Risk of Prostate Cancer Death
  • “This Is My Last Day on Earth”
  • ONS: Safe Handling of Chemotherapy
Click here to subscribe to our newsletter


 
SearchMedica Search Result

Find peer-reviewed literature and websites for practicing medical professionals

CME on Liver Cancer
Evidence on Liver Cancer
Guidelines on Liver Cancer
Patient Education on Liver Cancer
Clinical Trials on Liver Cancer
Practical Articles on Liver Cancer
Research and Reviews on Liver Cancer
All "Liver Cancer" results


CancerNetwork on Facebook

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy